This content is in French.
Porcine liver and human patient: an unprecedented and functional alliance
24 juin 2025

#Xenotransplantation #LiverTransplantation #GeneticallyModifiedPigLiver
The global shortage of organs hinders access to life-saving transplants, particularly for end-stage liver diseases. In a major medical breakthrough, a team of researchers from Xijing Hospital (China) performed a heterotopic auxiliary xenogeneic liver transplantation by implanting a genetically modified pig liver into a brain-dead human patient.
The objective was to assess the short-term viability, cross-species immune tolerance, and functional capacity of a porcine liver in a human. The graft remained functional for 10 days, demonstrating its potential as a temporary treatment for patients with acute liver failure.
The global shortage of organs hinders access to life-saving transplants, particularly for end-stage liver diseases. In a major medical breakthrough, a team of researchers from Xijing Hospital (China) performed a heterotopic auxiliary xenogeneic liver transplantation by implanting a genetically modified pig liver into a brain-dead human patient.
The objective was to assess the short-term viability, cross-species immune tolerance, and functional capacity of a porcine liver in a human. The graft remained functional for 10 days, demonstrating its potential as a temporary treatment for patients with acute liver failure.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Tao KS, et al. Gene-modified pig-to-human liver xenotransplantation. Nature. 2025;641:1029–1036.
View the source


